Paper40514723
ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital.
Tauziède-Espariat A and 14 others. Acta Neuropathol Commun, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital. Papers, record 40514723. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40514723
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| X-linked Nuclear Protein | Major topic |
| Glioma | Major topic |
| Isocitrate Dehydrogenase | Major topic |
| Brain Neoplasms | Major topic |
| Histones | Major topic |
| Humans | |
| Female | |
| Male | |
| Adult | |
| Middle Aged | |
| Mutation | |
| Aged | |
| Retrospective Studies | |
| Young Adult |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29809131 | Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations. | Clin Neuropathol | 2018 | https://conductscience.org/library/papers/29809131 | PubMed |
| 2 | 27311324 | ATRX immunostaining predicts IDH and H3F3A status in gliomas. | Acta Neuropathol Commun | 2016 | https://conductscience.org/library/papers/27311324 | PubMed |
| 3 | 36367829 | Mutations of FH and IDH may induce gliomagenesis by similar mechanisms. | J Neuropathol Exp Neurol | 2022 | https://conductscience.org/library/papers/36367829 | PubMed |
| 4 | 39707480 | Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/39707480 | PubMed |
| 5 | 19255330 | Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19255330 | PubMed |
| 6 | 38926805 | Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/38926805 | PubMed |
| 7 | 38874462 | FH-mutant glioma displaying the epigenetic signature of IDH-mutant astrocytomas. | J Neuropathol Exp Neurol | 2024 | https://conductscience.org/library/papers/38874462 | PubMed |
| 8 | 36933012 | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions. | Acta Neuropathol | 2023 | https://conductscience.org/library/papers/36933012 | PubMed |
| 9 | 39558399 | Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/39558399 | PubMed |
| 10 | 29564591 | Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. | Acta Neuropathol | 2018 | https://conductscience.org/library/papers/29564591 | PubMed |
| 11 | 39456052 | Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/39456052 | PubMed |
| 12 | 26647377 | Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. | Bioinformatics | 2016 | https://conductscience.org/library/papers/26647377 | PubMed |
| 13 | 37689804 | Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism. | Br J Cancer | 2023 | https://conductscience.org/library/papers/37689804 | PubMed |
| 14 | 32776277 | Infratentorial IDH-mutant astrocytoma is a distinct subtype. | Acta Neuropathol | 2020 | https://conductscience.org/library/papers/32776277 | PubMed |
| 15 | 24120142 | The somatic genomic landscape of glioblastoma. | Cell | 2013 | https://conductscience.org/library/papers/24120142 | PubMed |
| 16 | 33876327 | Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1. | Acta Neuropathol | 2021 | https://conductscience.org/library/papers/33876327 | PubMed |
| 17 | 27635946 | Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma. | Am J Surg Pathol | 2016 | https://conductscience.org/library/papers/27635946 | PubMed |
| 18 | 39848278 | High-Grade Astrocytoma With Piloid Features: Case Series and Review of a Recently Described Brain Tumor Entity. | Arch Pathol Lab Med | 2025 | https://conductscience.org/library/papers/39848278 | PubMed |
| 19 | 26741321 | Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas. | Histopathology | 2016 | https://conductscience.org/library/papers/26741321 | PubMed |
| 20 | 34850045 | Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component. | J Neuropathol Exp Neurol | 2021 | https://conductscience.org/library/papers/34850045 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42873435 | A two-stage model combining clinical and delta-radiomics features for prognosis in high-grade gliomas after chemoradiotherapy: a retrospective study. | Radiol Med | 2026 | https://conductscience.org/library/papers/42873435 | PubMed |
| 42747321 | High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/42747321 | PubMed |
| 40937216 | The Role of Vimentin, Synaptophysin, and Histone H3 Lysine 27 Methylation (H3K27me) as Surrogate Markers in the Diagnosis and Classification of Oligodendrogliomas and Diffuse Midline Gliomas: A Comprehensive Review. | Cureus | 2025 | https://conductscience.org/library/papers/40937216 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATRX | 546 | PubTator's text mining | https://conductscience.org/library/genes/546 | NCBI Gene |
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| IDH2 | 3418 | PubTator's text mining | https://conductscience.org/library/genes/3418 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40514723
GET https://conductscience.org/api/papers/v1/40514723/references?page=2